In Vitro Genetic Analysis of the RNA Binding Site of Vigilin, a Multi-KH-Domain Protein

REFERENCES

• Arning, S., P. Grüter, G. Bilbe, and A. Krämer 1996. Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA. RNA 2: 794–810.
   PubMed Web of Science ®Google Scholar
• Ashley, C. T.Jr., K. D. Wilkinson, D. Reines, and S. T. Warren 1993. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262: 563–566.
   PubMed Web of Science ®Google Scholar
• Bartel, D. P., M. L. Zapp, M. R. Green, and J. W. Szostak 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67: 529–536.
   PubMed Web of Science ®Google Scholar
• Battiste, J. L., R. Tan, A. D. Frankel, and J. R. Williamson 1994. Binding of an HIV Rev peptide to Rev responsive element RNA induces formation of purine-purine base pairs. Biochemistry 33: 2741–2747.
   PubMed Web of Science ®Google Scholar
• Beelman, C. A., and R. Parker 1995. Degradation of mRNA in eukaryotes. Cell 81: 179–183.
   PubMed Web of Science ®Google Scholar
• Belasco, J., and G. Brawerman 1993. Control of messenger RNA stability. Academic Press Inc., San Diego, Calif.
   Google Scholar
• Binkley, J., P. Allen, D. M. Brown, L. Green, C. Tuerk, and L. Gold 1995. RNA ligands to human nerve growth factor. Nucleic Acids Res. 23: 3198–3205.
   PubMed Web of Science ®Google Scholar
• Blackwell, T. K., and H. Weintraub 1990. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250: 1104–1110.
   PubMed Web of Science ®Google Scholar
• Blume, J. E., and D. J. Shapiro 1989. Ribosome loading, but not protein synthesis, is required for estrogen stabilization of Xenopus laevis vitellogenin mRNA. Nucleic Acids Res. 17: 9003–9014.
   PubMed Web of Science ®Google Scholar
• Brock, M. L., and D. J. Shapiro 1983. Estrogen stabilizes vitellogenin mRNA against cytoplasmic degradation. Cell 34: 207–214.
   PubMed Web of Science ®Google Scholar
• Brown, D., J. Brown, C. Kang, L. Gold, and P. Allen 1997. Single-stranded RNA recognition by the bacteriophage T4 translational repressor, regA. J. Biol. Chem. 272: 14969–14974.
   PubMedGoogle Scholar
• Buckanovich, R. J., and R. B. Darnell 1997. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol. Cell. Biol. 17: 3194–3201.
   PubMedGoogle Scholar
• Buckanovich, R. J., Y. Y. Yang, and R. B. Darnell 1996. The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J. Neurosci. 16: 1114–1122.
   PubMed Web of Science ®Google Scholar
• Burd, C. G., and G. Dreyfuss 1994. Conserved structures and diversity of functions of RNA-binding proteins. Science 265: 615–621.
   PubMed Web of Science ®Google Scholar
• Burd, C. G., and G. Dreyfuss 1994. RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J. 13: 1197–1204.
   PubMed Web of Science ®Google Scholar
• Cadwell, R. C., and G. F. Joyce 1992. Randomization of genes by PCR mutagenesis. PCR Methods Appl. 2: 28–33.
   PubMedGoogle Scholar
• Casey, J. L., D. M. Koeller, V. C. Ramin, R. D. Klausner, and J. B. Harford 1989. Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3′ untranslated region of the mRNA. EMBO J. 8: 3693–3699.
   PubMed Web of Science ®Google Scholar
• Chagnovich, D., B. E. Fayos, and S. L. Cohn 1996. Differential activity of ELAV-like RNA-binding proteins in human neuroblastoma. J. Biol. Chem. 271: 33587–33591.
   PubMedGoogle Scholar
• Chen, C. Y., and A. B. Shyu 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20: 465–470.
   PubMed Web of Science ®Google Scholar
• Chiang, C. M., and R. G. Roeder 1993. Expression and purification of general transcription factors by FLAG epitope-tagging and peptide elution. Peptide Res. 6: 62–64.
   PubMedGoogle Scholar
• Dejgaard, K., and H. Leffers 1996. Characterisation of the nucleic-acid-binding activity of KH domains. Different properties of different domains. Eur. J. Biochem. 241: 425–431.
   PubMedGoogle Scholar
• DeMaria, C. T., and G. Brewer 1996. AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation. J. Biol. Chem. 271: 12179–12184.
   PubMed Web of Science ®Google Scholar
• Devereux, J., P. Haeberli, and O. Smithies 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12: 387–395.
   PubMed Web of Science ®Google Scholar
• Dodson, R. E., M. R. Acena, and D. J. Shapiro 1995. Tissue distribution, hormone regulation and evidence for a human homologue of the estrogen-inducible Xenopus laevis vitellogenin mRNA binding protein. J. Steroid Biochem. Mol. Biol. 52: 505–515.
   PubMedGoogle Scholar
• Dodson, R. E., and D. J. Shapiro 1994. An estrogen-inducible protein binds specifically to a sequence in the 3′ untranslated region of estrogen-stabilized vitellogenin mRNA. Mol. Cell. Biol. 14: 3130–3138.
   PubMed Web of Science ®Google Scholar
• Dodson, R. E., and D. J. Shapiro 1997. Vigilin, a ubiquitous protein with 14 K homology domains, is the estrogen-inducible vitellogenin mRNA 3′-untranslated region-binding protein. J. Biol. Chem. 272: 12249–12252.
   PubMed Web of Science ®Google Scholar
• Gibson, T. J., J. D. Thompson, and J. Heringa 1993. The KH domain occurs in a diverse set of RNA-binding proteins that include the antiterminator NusA and is probably involved in binding to nucleic acid. FEBS Lett. 324: 361–366.
   PubMed Web of Science ®Google Scholar
• Gold, L., B. Polisky, O. Uhlenbeck, and M. Yarus 1995. Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64: 763–797.
   PubMed Web of Science ®Google Scholar
• Görlach, M., C. G. Burd, and G. Dreyfuss 1994. The determinants of RNA-binding specificity of the heterogeneous nuclear ribonucleoprotein C proteins. J. Biol. Chem. 269: 23074–23078.
   PubMedGoogle Scholar
• Green, S., P. Walter, V. Kumar, A. Krust, J. M. Bornert, P. Argos, and P. Chambon 1986. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320: 134–139.
   PubMed Web of Science ®Google Scholar
• Heinrichs, V., and B. S. Baker 1995. The Drosophila SR protein RBP1 contributes to the regulation of doublesex alternative splicing by recognizing RBP1 RNA target sequences. EMBO J. 14: 3987–4000.
   PubMedGoogle Scholar
• Jellinek, D., C. K. Lynott, D. B. Rifkin, and N. Janjic 1993. High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc. Natl. Acad. Sci. USA 90: 11227–11231.
   PubMed Web of Science ®Google Scholar
• Kjems, J., B. J. Calnan, A. D. Frankel, and P. A. Sharp 1992. Specific binding of a basic peptide from HIV-1 Rev. EMBO J. 11: 1119–1129.
   PubMed Web of Science ®Google Scholar
• Kruse, C., A. Grünweller, H. Notbohm, S. Kügler, W. G. Purschke, and P. K. Müller 1996. Evidence for a novel cytoplasmic tRNA-protein complex containing the KH-multidomain protein vigilin. Biochem. J. 320: 247–252.
   PubMedGoogle Scholar
• Kügler, S., A. Grünweller, C. Probst, M. Klinger, P. K. Müller, and C. Kruse 1996. Vigilin contains a functional nuclear localisation sequence and is present in both the cytoplasm and the nucleus. FEBS Lett. 382: 330–334.
   PubMed Web of Science ®Google Scholar
• Kühn, L. C., A. McClelland, and F. H. Ruddle 1984. Gene transfer, expression, and molecular cloning of the human transferrin receptor gene. Cell 37: 95–103.
   PubMed Web of Science ®Google Scholar
• Lacadena, J., A. Martı́nez del Pozo, J. L. Barbero, J. M. Mancheño, M. Gasset, M. Oñaderra, C. López-Otı́n, S. Ortega, J. Garcı́a, and J. G. Gavilanes 1994. Overproduction and purification of biologically active native fungal alpha-sarcin in Escherichia coli. Gene 142: 147–151.
   PubMedGoogle Scholar
• Leffers, H., K. Dejgaard, and J. E. Celis 1995. Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains. Eur. J. Biochem. 230: 447–453.
   PubMedGoogle Scholar
• Levine, T. D., F. Gao, P. H. King, L. G. Andrews, and J. D. Keene 1993. Hel-N1: an autoimmune RNA-binding protein with specificity for 3′ uridylate-rich untranslated regions of growth factor mRNAs. Mol. Cell. Biol. 13: 3494–3504.
   PubMed Web of Science ®Google Scholar
• Liu, M. Y., H. Yang, and T. Romeo 1995. The product of the pleiotropic Escherichia coli gene csrA modulates glycogen biosynthesis via effects on mRNA stability. J. Bacteriol. 177: 2663–2672.
   PubMedGoogle Scholar
• Lorincz, M. A., J. A. Holt, and G. L. Greene 1985. Monoclonal antibody recognition of multiple forms of estrogen receptor tagged with [125I]methoxy-iodovinyl estradiol in ovarian carcinomas. J. Clin. Endocrinol. Metab. 61: 412–417.
   PubMedGoogle Scholar
• Matunis, M. J., W. M. Michael, and G. Dreyfuss 1992. Characterization and primary structure of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein. Mol. Cell. Biol. 12: 164–171.
   PubMed Web of Science ®Google Scholar
• McKnight, G. L., J. Reasoner, T. Gilbert, K. O. Sundquist, B. Hokland, P. A. McKernan, J. Champagne, C. J. Johnson, M. C. Bailey, R. Holly, P. J. O’Hara, and J. F. Oram 1992. Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells. J. Biol. Chem. 267: 12131–12141.
   PubMed Web of Science ®Google Scholar
• Müllner, E. W., B. Neupert, and L. C. Kühn 1989. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA. Cell 58: 373–382.
   PubMed Web of Science ®Google Scholar
• Musco, G., G. Stier, C. Joseph, M. A. Castiglione Morelli, M. Nilges, T. J. Gibson, and A. Pastore 1996. Three-dimensional structure and stability of the KH domain: molecular insights into the fragile X syndrome. Cell 85: 237–245.
   PubMed Web of Science ®Google Scholar
• Nandabalan, K., and G. S. Roeder 1995. Binding of a cell-type-specific RNA splicing factor to its target regulatory sequence. Mol. Cell. Biol. 15: 1953–1960.
   PubMedGoogle Scholar
• Neu-Yilik, G., H. Zorbas, T. R. Gloe, H. M. Raabe, T. A. Hopp-Christensen, and P. K. Müller 1993. Vigilin is a cytoplasmic protein. A study on its expression in primary cells and in established cell lines of different species. Eur. J. Biochem. 213: 727–736.
   PubMedGoogle Scholar
• Nielsen, D. A., and D. J. Shapiro 1990. Estradiol and estrogen receptor-dependent stabilization of a minivitellogenin mRNA lacking 5,100 nucleotides of coding sequence. Mol. Cell. Biol. 10: 371–376.
   PubMedGoogle Scholar
• Plenz, G., Y. Gan, H. M. Raabe, and P. K. Müller 1993. Expression of vigilin in chicken cartilage and bone. Cell Tissue Res 273: 381–389.
   PubMedGoogle Scholar
• Plenz, G., S. Kügler, S. Schnittger, H. Rieder, C. Fonatsch, and P. K. Müller 1994. The human vigilin gene: identification, chromosomal localization and expression pattern. Hum. Genet. 93: 575–582.
   PubMedGoogle Scholar
• Ree, A. H., H. K. Knutsen, B. F. Landmark, W. Eskild, and V. Hansson 1992. Down-regulation of messenger ribonucleic acid (mRNA) for the estrogen receptor (ER) by phorbol ester requires ongoing RNA synthesis but not protein synthesis. Is hormonal control of ER mRNA degradation mediated by an RNA molecule? Endocrinology 131: 1810–1814.
   PubMedGoogle Scholar
• Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59: 423–450.
   PubMedGoogle Scholar
• Saceda, M., C. Knabbe, R. B. Dickson, M. E. Lippman, D. Bronzert, R. K. Lindsey, M. M. Gottardis, and M. B. Martin 1991. Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. J. Biol. Chem. 266: 17809–17814.
   PubMedGoogle Scholar
• Schmidt, C., B. Henkel, E. Poschl, H. Zorbas, W. G. Purschke, T. R. Gloe, and P. K. Müller 1992. Complete cDNA sequence of chicken vigilin, a novel protein with amplified and evolutionary conserved domains. Eur. J. Biochem. 206: 625–634.
   PubMedGoogle Scholar
• Siebel, C. W., A. Admon, and D. C. Rio 1995. Soma-specific expression and cloning of PSI, a negative regulator of P element pre-mRNA splicing. Genes Dev. 9: 269–283.
   PubMedGoogle Scholar
• Singh, R., J. Valcarcel, and M. R. Green 1995. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268: 1173–1176.
   PubMed Web of Science ®Google Scholar
• Siomi, H., M. Choi, M. C. Siomi, R. L. Nussbaum, and G. Dreyfuss 1994. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77: 33–39.
   PubMed Web of Science ®Google Scholar
• Siomi, H., M. J. Matunis, W. M. Michael, and G. Dreyfuss 1993. The pre-mRNA binding K protein contains a novel evolutionarily conserved motif. Nucleic Acids Res. 21: 1193–1198.
   PubMed Web of Science ®Google Scholar
• Siomi, M. C., H. Siomi, W. H. Sauer, S. Srinivasan, R. L. Nussbaum, and G. Dreyfuss 1995. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J. 14: 2401–2408.
   PubMedGoogle Scholar
• Siomi, M. C., Y. Zhang, H. Siomi, and G. Dreyfuss 1996. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol. Cell. Biol. 16: 3825–3832.
   PubMed Web of Science ®Google Scholar
• Swanson, M. S., and G. Dreyfuss 1988. Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities. Mol. Cell. Biol. 8: 2237–2241.
   PubMed Web of Science ®Google Scholar
• Tacke, R., and J. L. Manley 1995. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14: 3540–3551.
   PubMed Web of Science ®Google Scholar
• Takagaki, Y., and J. L. Manley 1997. RNA recognition by the human polyadenylation factor CstF. Mol. Cell. Biol. 17: 3907–3914.
   PubMedGoogle Scholar
• Tsai, D. E., D. S. Harper, and J. D. Keene 1991. U1-snRNP-A protein selects a ten nucleotide consensus sequence from a degenerate RNA pool presented in various structural contexts. Nucleic Acids Res. 19: 4931–4936.
   PubMed Web of Science ®Google Scholar
• Tuerk, C., S. Eddy, D. Parma, and L. Gold 1990. Autogenous translational operator recognized by bacteriophage T4 DNA polymerase. J. Mol. Biol. 213: 749–761.
   PubMedGoogle Scholar
• Wang, J., Z. Dong, and L. R. Bell 1997. Sex-lethal interactions with protein and RNA. Roles of glycine-rich and RNA binding domains. J. Biol. Chem. 272: 22227–22235.
   PubMedGoogle Scholar
• Wang, L. L., S. Richard, and A. S. Shaw 1995. P62 association with RNA is regulated by tyrosine phosphorylation. J. Biol. Chem. 270: 2010–2013.
   PubMedGoogle Scholar
• Wang, X., and S. A. Liebhaber 1996. Complementary change in cis determinants and trans factors in the evolution of an mRNP stability complex. EMBO J. 15: 5040–5051.
   PubMedGoogle Scholar
• Wintersberger, U., C. Kühne, and A. Karwan 1995. Scp160p, a new yeast protein associated with the nuclear membrane and the endoplasmic reticulum, is necessary for maintenance of exact ploidy. Yeast 11: 929–944.
   PubMed Web of Science ®Google Scholar
• Zuker, M. 1989. Computer prediction of RNA structure. Methods Enzymol. 180: 262–288.
   PubMed Web of Science ®Google Scholar